EuroSIDA - Clinical and virological outcomes for European people living with HIV

EuroSIDA’s primary objective is to prospectively study clinical, therapeutic, demographic, virological and laboratory data as well as plasma from people living with HIV across Europe to determine the long-term virological, immunological and clinical outcome in a large cohort of consecutive enrolled study participants. The specific objectives, falling into four main categories, are as follows:   

• To assess the factors associated with the clinical, immunological and virological course of HIV infection and HIV-related co-infections and co-morbidities  
• To detect current or emerging late onset adverse events among persons on ART 
• To continue surveillance of HIV in clinics around Europe to describe temporal changes and regional difference
• To investigate the long-term clinical outcomes of common co-infections and co-morbidities and the impact of treatment

na

HIV-1 Infection

na